Sushil Patel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bain Capital Life Sciences Investors LLC bought a new stake in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 1,112,396 shares of the company’s stock, valued at approximately $31,904,000. Revolution Medicines comprises 3.1% of Bain Capital Life […]

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has been given an average rating of “Buy” by the ten analysts that are currently covering the firm, MarketBeat reports. Nine investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target […]

Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) CEO Sushil Patel sold 20,194 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $6.47, for a total value of $130,655.18. Following the completion of the sale, the chief executive officer now owns […]

Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) CEO Sushil Patel sold 20,194 shares of the company’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $6.47, for a total value of $130,655.18. Following the completion of the sale, the chief executive officer now owns 212,014 shares […]

SAN DIEGO, April 07, 2024 -- Replimune Group, Inc. , a clinical stage biotechnology company pioneering the development of a novel portfolio of oncolytic immunotherapies, today announced the...